Search Results
Results 451 - 500 of 910
< 5 6 7 8 9 10 11 12 13 14 15 >
Jimenez, Carlos - - 2009
- - 2009
Jones, J.L. - - 2009
Alemtuzumab, formally known as Campath-1H, is a humanized monoclonal antibody directed against CD52, a protein on the surface of lymphocytes and monocytes with unknown function. A single dose of alemtuzumab leads to a rapid, profound and prolonged lymphopenia. A Phase II trial has shown that alemtuzumab reduces the risk of ...
Murray, T.J. - - 2009
The first illustration of multiple sclerosis (MS) was by a young Scottish physician and artist, Dr Robert Carswell. Recognized as a talented illustrator by his teachers, he was encouraged to create an anatomy and pathology atlas. He spent years in the hospitals and mortuaries of Paris and Lyon painting watercolours ...
Trojano, M. - - 2009
The randomized controlled trial (RCT) is considered to be the 'gold standard' for providing evidence on drug efficacy. However, particularly for answering long-term questions in chronic diseases such as multiple sclerosis (MS), RCTs are often not feasible because of their size, duration, ethical constraints and costs. Data derived from observational ...
Shams, P.N. - - 2009
Acute demyelinating optic neuritis (ON) is the initial presentation in approximately 20% of cases of multiple sclerosis (MS) and is characterized by unilateral, subacute, painful visual loss without systemic or neurological symptoms. The Optic Neuritis Treatment Trial (ONTT) has provided valuable insights into both the natural history and clinical course ...
Larner, A.J. - - 2009
Although cognitive problems in multiple sclerosis (MS) are increasingly recognized, acute amnesia in MS appears to be very rare. Hence, this presentation should always prompt consideration of other diagnoses. Nonetheless, as illustrated by the following case report, acute onset of demyelinating disease with the clinical phenotype of amnesia may on ...
Bates, D. - - 2009
Kesenne, Stefan - - 2009
In this contribution, based on a simple theoretical approach, we try to show that the number of teams that is optimal to a monopoly league, being a cartel of clubs and acting in the interest of the participating or insider clubs only, is smaller than the welfare optimal number of ...
Paul, Rodney - - 2009
Betting market odds for Major League Baseball are used to examine the level of uncertainty of outcome, an ex-ante form of competitive balance. The efficient markets hypothesis cannot be rejected for the years 1990-2006 in Major League Baseball. Therefore, the odds provide an ex-ante measure of the uncertainty of outcome ...
Alexander, Donald - - 2009
This paper explores the impact of intercollegiate athletic performance on tuition rates. A number of recent studies have examined the advertising effect generated by participation in intercollegiate sports. These studies have attempted to ascertain whether athletic performance improves student quality, graduation rates, and state appropriations. Only one previous paper examines ...
Feddersen, Arne - - 2009
Using the case of the new stadiums for the FIFA World Cup 2006 in Germany, this paper is the first multivariate work that examines the potential income and employment effects of new stadiums outside of the USA. This study is also the first work on this topic that conducts tests ...
Potter, Polyxeni - - 2009
Liyanapathirana, Veranja - - 2009
Chen, Lin - - 2009
de Mera, Isabel G. - - 2009
Azevedo, Raimunda - - 2009
< 5 6 7 8 9 10 11 12 13 14 15 >